Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CAR-T
Sort By
Newest First
1 / 3
LOGIC GATES
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-03
Mar 14, 2025
Immuno-oncology
Immuno-Oncology at the Forefront of Cancer Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-10
Mar 02, 2025
Anixa Biosciences
Approval
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences
PR-02-25-NI-16
Feb 19, 2025
EXUMA Biotechnology
Clinical Trials
EXUMA Biotech Announces Phase 1 Results for its Autologous HER2 Directed CAR-T Product at ASCO GI 2025
EXUMA Biotechnology
PR-01-25-NI-26
Feb 11, 2025
Carsgen Therapeutics
Clinical Trials
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
Carsgen Therapeutics
PR-02-25-NI-09
Feb 11, 2025
Biopreservation
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Vitrafy
PAO-10-24-RTM-02
Nov 04, 2024
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33
Nov 01, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04
Sep 05, 2023
Terumo Blood and Cell Technologies
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03
Feb 23, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
PAO-12-022-CL-04
Jan 03, 2023
Umoja Biopharma
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06
Nov 11, 2022
Gladstone Institutes
CRISPR Research Innovation
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
Gladstone Institutes
PR-M08-22-05
Aug 25, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03
Aug 09, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06
Jul 02, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04
Jun 24, 2022
Anixa Biosciences
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
Mar 30, 2022
Juntendo University
Immunotherapy Research
Genetically Engineered Dual Receptor T-cells: Double Trouble for Cancer Cells
Juntendo University
PR-M01-22-23
Jan 31, 2022
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
Mike Nicholson, Ph.D.
Inceptor Bio
PAO-10-21-CL-14
Oct 22, 2021
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
David Y. H. Chang, Ph.D.
WuXi Advanced Therapies
PAO-05-21-CL-05
May 27, 2021
Cell and Gene Therapy
CAR-T Cell and Gene Therapy Market: Challenges and Opportunities
Jason Rahal
Nice Insight
PA1009
Apr 21, 2021
1 / 3
